DOI: 10.4244/EIJV7I1A5

Patrick Washington Serruys: a view from across the Atlantic

Spencer B. King*, III, MD, MACC

Patrick has always “accused” me of being among the most European of the American cardiologists. I don’t know if that is because I don’t own a gun or because I favour universal healthcare, and I don’t even know if it’s true. But I know Patrick to be, in some respects, American. It was his grandfather I believe who was a diplomat and for a while stationed in America that caused Patrick’s parents to bestow his first honour, his middle name “Washington”. In any case, my relationship with Patrick began in the early days of angioplasty when he, Paul Hugenholtz (his mentor) and Michel Bertrand, asked me to become a fellow of the European Society of Cardiology. It has for me been a relationship of admiration and amazement for his accomplishments as he has occupied the centre court of so many developments of our field. Some accomplishments have come quickly while others have marinated over many years. The BENESTENT trial he led was pivotal in quickly establishing stenting as the default strategy in coronary interventions, and his involvement in the first-in-man trials of drug-eluting stenting was so surprising that he said, “Don’t wake me. I am dreaming!” Other developments have taken more time.

A conversation he, David Holmes and I had 23 years ago led to early experiments on bioerodible polymeric stents. Now, more than two decades later, Patrick presents the results of the RESORB trial at ACC 2011 where he also received the most fitting tribute for his lifetime of achievements.

Beyond his well-known landmark contributions in illuminating the role of stenting, drug-eluting stenting, and now bioerodable stenting, and beyond the important collaboration with scientists of multiple disciplines at the Erasmus University, and beyond the legion of his trainees who will forge the future of the specialty, I respect the man and his family. As my wife, Gail and I travelled many times with Patrick, Danielle and their children, Michael, Gregory and Olivia, Ilearned a lot about the man and his priorities.

Finally, as Editor of JACC: Cardiovascular Interventions, it was my pleasure to support the development of EuroIntervention. Just as the journals aim to provide the best forum for disseminating knowledge and hopefully wisdom in interventional cardiology, the parent organisations, the American College of Cardiology and the European Society of Cardiology, have the capacity to enhance cardiovascular health throughout the world. Patrick Washington Serruys has always been a strong advocate and participant in forging collaborate efforts. It was a thrill for me to see him receive the Lifetime Achievement Award from the ACC as the most productive investigator in our field and equally a pleasure to say a few words in EuroIntervention about him.

From someone who has been branded with a “lifetime achievement award”, my only advice is to accept the “award” but to continue the lifetime and the achievements. And keep on “dreaming!”

Volume 7 Number 1
May 17, 2011
Volume 7 Number 1
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved